These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9219732)

  • 1. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells.
    Abbas Abidi SM; Howard EW; Dmytryk JJ; Pento JT
    Clin Exp Metastasis; 1997 Jul; 15(4):432-9. PubMed ID: 9219732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.
    Abidi SM; Howard EW; Dmytryk JJ; Pento JT
    Clin Exp Metastasis; 1998 Apr; 16(3):235-41. PubMed ID: 9568641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of antiestrogens on the migration of breast cancer cells using an in vitro wound model.
    Mathew AC; Rajah TT; Hurt GM; Abbas Abidi SM; Dmytryk JJ; Pento JT
    Clin Exp Metastasis; 1997 Jul; 15(4):393-9. PubMed ID: 9219727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells.
    Smolnikar K; Löffek S; Schulz T; Michna H; Diel P
    Breast Cancer Res Treat; 2000 Oct; 63(3):249-59. PubMed ID: 11110059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of a novel antiestrogen (Analog II) on human breast cancer cells.
    Jain PT; Rajah TT; Pento JT
    Anticancer Drugs; 1997 Nov; 8(10):964-73. PubMed ID: 9436640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.
    Couissi D; Dubois V; Remacle C; Schonne E; Trouet A
    Clin Exp Metastasis; 1997 Jul; 15(4):349-60. PubMed ID: 9219723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells.
    Tong GM; Rajah TT; Zang XP; Pento JT
    Anticancer Res; 2002; 22(1A):103-6. PubMed ID: 12017270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
    Azzam HS; Arand G; Lippman ME; Thompson EW
    J Natl Cancer Inst; 1993 Nov; 85(21):1758-64. PubMed ID: 8411260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V; Jensen EV; Knabbe C
    Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer.
    Cook KL; Wärri A; Soto-Pantoja DR; Clarke PA; Cruz MI; Zwart A; Clarke R
    Clin Cancer Res; 2014 Jun; 20(12):3222-32. PubMed ID: 24928945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J; Kitlen JW; Briand P; Labrie F; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2003 Mar; 84(4):469-78. PubMed ID: 12732292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
    Journe F; Chaboteaux C; Magne N; Duvillier H; Laurent G; Body JJ
    Breast Cancer Res; 2006; 8(1):R2. PubMed ID: 16417650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
    Bouker KB; Skaar TC; Fernandez DR; O'Brien KA; Riggins RB; Cao D; Clarke R
    Cancer Res; 2004 Jun; 64(11):4030-9. PubMed ID: 15173018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
    Thompson EW; Katz D; Shima TB; Wakeling AE; Lippman ME; Dickson RB
    Cancer Res; 1989 Dec; 49(24 Pt 1):6929-34. PubMed ID: 2582435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The estrogenic and antiestrogenic activities of droloxifene in human breast cancers.
    Kawamura I; Mizota T; Lacey E; Tanaka Y; Manda T; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1993 Sep; 63(1):27-34. PubMed ID: 8271528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Moriya T
    Breast Cancer; 2016 May; 23(3):425-36. PubMed ID: 25552385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.